PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportspheochromocytoma
MeSH D010673 - pheochromocytoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010235:Paraganglioma
0 Companies
0 Drugs
Success rate
D010673: 
Pheochromocytoma
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPropranolol hydrochloride Propranolol  1987-10-07   
Hydrochlorothiazide, Propranolol hydrochloride Propranolol Hydrochlorothiazide  1988-12-01   
MylanPropranolol hydrochloride Propranolol  1985-11-19   
Rising PharmaceuticalsPropranolol hydrochloride Propranolol  2007-02-15   
Hydrochlorothiazide, Propranolol hydrochloride Propranolol Hydrochlorothiazide  1987-03-04   
Phenoxybenzamine Phenoxybenzamine  2023-06-20   
SandozPropranolol hydrochloride Propranolol  1988-07-05   
WyethPropranolol hydrochloride Inderal  1982-01-01   
Hydrochlorothiazide, Propranolol hydrochloride Inderide  1985-07-03   
Hydrochlorothiazide, Propranolol hydrochloride Inderide-  1982-01-01   
Bausch Health CompaniesMetyrosine Demser  1982-01-01   
Merck & CoPropranolol hydrochloride Propranolol  1985-08-06   
Zydus TherapeuticsPropranolol hydrochloride Propranolol  2011-03-25   
Warner ChilcottPropranolol hydrochloride Propranolol  1986-09-15   
Hydrochlorothiazide, Propranolol hydrochloride Propranolol Hydrochlorothiazide  1988-01-26   
Amneal PharmaceuticalsMetyrosine Metyrosine  2020-07-24   
Phenoxybenzamine Phenoxybenzamine  2020-10-27   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
62%
8/13
Phase 2
7%
2/29
Phase 3
45%
5/11
Approved: 3Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use